Global Automated Autoinjectors Market Is Expected To Reach Around USD 6.74 Billion By 2032

Zion Market Research has published a new report titled “Automated Autoinjectors Market By Design (Customized Autoinjector and Standardized Autoinjector), By Usage (Reusable Autoinjector and Disposable Autoinjector), By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, and Others), By End-User (Hospitals & Clinics and Home Care Settings), and By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032”. According to the report, the global automated autoinjectors market was valued at approximately USD 3.76 billion in 2023 and is expected to generate around USD 6.74 billion by the end of 2032, at a CAGR of around 6.70% between 2024 and 2032.

Automated autoinjectors are needle-based medical devices used for the administration of fixed doses for specific drug doses. It is used for self-administration by untrained personnel or patients, as it is easy to handle. Furthermore, these devices are used for various allergic reactions, such as wheezing, trouble breathing, stomach pain, nausea, dizziness, swelling on the face, lips, mouth, and tongue and skin allergies, like hives, itching, flushing, etc. Furthermore, the administration site depends on the nature of the drug. For example, insulin shots are injected into the abdomen for quick action. Automated autoinjectors are easy to use and have various advantages, such as reduced needle phobia anxiety, lowered chances of needlestick injuries, better efficacy, and consistent dose accuracy, which, in turn, are likely to propel the automated autoinjectors market globally in the future.

Browse the full “Automated Autoinjectors Market By Design (Customized Autoinjector and Standardized Autoinjector), By Usage (Reusable Autoinjector and Disposable Autoinjector), By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, and Others), By End-User (Hospitals & Clinics and Home Care Settings), and By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032” Report at https://www.zionmarketresearch.com/report/automated-autoinjectors-market

The automated autoinjectors market is divided on the basis of design, application, usage, and end-user. By design, the automated autoinjectors market includes customized autoinjectors and standardized autoinjectors. Customized autoinjectors held the largest market share in 2023 in terms of revenue. Standardized autoinjectors are likely to grow rapidly in the future.

By usage, the market is segmented into reusable autoinjectors and disposable autoinjectors. Reusable autoinjectors held the largest market share in 2023 in terms of revenue, due to their cost-effectiveness and multi-use nature. Furthermore, disposable autoinjectors are intended for better handling and are more popular along with offering enhanced safety features, making it them a preferable option. Thus, this segment is likely to register a high CAGR over the forecast timeline.

The application segment includes anaphylaxis, rheumatoid arthritis, multiple sclerosis, diabetes, and others. Rheumatoid arthritis held a significant share in the market in 2023, owing to the rising prevalence of rheumatoid arthritis (RA). According to Sanofi, more than 400,000 people in the UK suffered from RA in 2017. This number is likely to increase further in the upcoming years. 

By end-user, the market is segmented into hospitals and clinics and home care settings. Home care settings held a major market share of the market in 2023, due to the ease of monitoring and operation of these devices to deliver early emergency care at affordable rates, as these are designed with a user-centric approach to reducing user-associated risk.

By region, North America dominated the global automated autoinjectors market in 2023. The presence of several leading players and favorable reimbursement scenarios are major factors likely to propel the North American automated autoinjectors market in the future. The Asia Pacific automated autoinjectors market is projected to witness rapid growth in the next few years, owing to the rising awareness among consumers regarding the advanced treatment methods that are available. Lucrative growth opportunities in Japan, India, and China and technological advancements, increased healthcare expenditure, mandatory healthcare insurance, and the rising number of global companies catering to the unmet medical needs of the regional population are likely to further propel the automated autoinjectors market growth in this region.

Some leading players in the global automated autoinjectors market include Unilife Corporation, Becton, Dickinson & Co., Biogen Idec, Pfizer, Inc., Mylan N.V., Sanofi, Owen Mumford, Teva Pharmaceutical, Amgen, Ypsomed, AbbVie, and Scandinavian Health Ltd.

This report segments the global automated autoinjectors market into:

Global Automated Autoinjectors Market: Design Analysis

• Customized Autoinjector
• Standardized Autoinjector

Global Automated Autoinjectors Market: Usage Analysis

• Reusable Autoinjector
• Disposable Autoinjector

Global Automated Autoinjectors Market: Application Analysis

• Anaphylaxis
• Rheumatoid Arthritis
• Multiple Sclerosis
• Diabetes
• Others

Global Automated Autoinjectors Market: End-User Analysis

• Hospitals and Clinics
• Home Care Settings

Global Automated Autoinjectors Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com